|
|
Home |
|
|
|
|
|
Joe,Young Ae |
Á¶¿µ¾Ö(Àç»ýÀÇÇÐ) |
|
|
|
¿¬µµ |
Çб³ |
Àü°ø |
ÇÐÀ§ |
1988³â-1992³â |
¼¿ï´ëÇб³ ¾àÇдëÇÐ ¾àÇаú |
»ýÈÇÐ |
¹Ú»ç |
1986³â-1988³â |
¼¿ï´ëÇб³ ¾àÇдëÇÐ ¾àÇаú |
»ýÈÇÐ |
¼®»ç |
1982³â-1986³â |
¼¿ï´ëÇб³ ¾àÇдëÇÐ ¾àÇаú |
¾àÇÐ |
Çлç |
|
|
¿¬µµ |
±â°ü |
Á÷À§ |
2010³â-ÇöÀç |
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ÀÇ»ý¸í°úÇб³½Ç & ¾Ï¿¬±¸¼Ò |
±³¼ö |
2005³â-2010³â |
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¾Ï¿¬±¸¼Ò |
ºÎ±³¼ö |
2000³â-2005³â |
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¾Ï¿¬±¸¼Ò |
Á¶±³¼ö |
1997³â-2000³â |
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¾Ï¿¬±¸¼Ò |
ÀüÀÓ°»ç |
1992³â-1997³â |
¹Ì±¹ National Institutes of Health |
Post-Doc. |
|
|
±â°£ |
ÇÐȸ¸í/±â°ü |
Á÷À§ |
2014³â |
Á¦24ȸ °úÇбâ¼ú ¿ì¼ö³í¹®»ó |
Çѱ¹°úÇбâ¼ú´ÜüÃÑ¿¬ÇÕȸ |
2009³â-ÇöÀç |
Biomolecules & Therapeutics(www.biomolther.org) |
Editor-in-Chief |
2003³â-ÇöÀç |
American Association for Cancer Research |
Á¤È¸¿ø |
2010-ÇöÀç |
International Society for Stem Cell Research |
Á¤È¸¿ø |
2008³â |
¿ì¼ö¿¬±¸ÀÚ»ó |
´ëÇѾÏÇÐȸ |
2008³â |
13th World Congress on Advances in Oncology and 11th International Symposium on Molecular Medicine |
Award for an outstanding achievement |
2010³â-ÇöÀç |
Çѱ¹ÀÀ¿ë¾à¹°ÇÐȸ |
ÀÌ»ç |
2015³â-ÇöÀç |
Çѱ¹Ç÷°ü»ý¹°ÇÐȸ |
ÀÌ»ç |
2004³â |
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ |
ÇмúÀ§¿ø |
2003³â |
Çѱ¹ºÐÀÚ¼¼Æ÷»ý¹°ÇÐȸ |
ÃâÆÇÀ§¿ø |
|
|
▫ »ý¹°Á¤º¸ÇÐ (À¯ÀüÀÚ¿Í ´Ü¹éÁú ºÐ¼®¿¡ °üÇÑ ½Ç¿ëÁöħ¼) °ø¿ª. ±¸È¿Á¤, ±èÁ¤Èñ, ±èÁö¿µ, ±èÈ«Èñ, ¹®¾Ö¸®, ¹ÚÇö¼º, ¾È»óÇö, ¿ÀÀ¯°æ, À̳ª°æ, À̹̿Á, À̼÷°æ, À̼÷Çâ, ÀÌ¿µÁÖ, ÀÌ¿ë±Ô, ÀÌÀº¼÷, Á¤¼±ÁÖ, Á¤À̼÷, Á¶¿µ¾Ö. 2003. µµ¼ÃâÆÇ ¿ùµå»çÀ̾𽺠|
|
|
|
|
|
|
±¸ ºÐ |
Ãâ¿ø/µî·Ï |
ÁöÀûÀç»ê±Ç(ƯÇã)¸í |
µî·Ï(Ãâ¿ø)¹øÈ£ |
µî·Ï(Ãâ¿ø)ÀÏ |
°øµ¿¹ß¸íÀÚ |
±¹³» |
µî·Ï |
Ç÷°ü½Å»ý°ú ¾ÏÀÇ ¼ºÀåÀ» ¾ïÁ¦ÇÏ´Â Å©¸µ±Û µµ¸ÞÀÎ 1-2 ´Ü¹éÁú Á¶¼º¹° ¹× ÀÌÀÇ ¿ëµµ |
0538465 |
2005.12 |
Á¶¿µ¾Ö,À̼ö¿µ |
±¹Á¦ |
Ãâ¿ø |
Ç÷°ü½Å»ý ¾ïÁ¦ È°¼ºÀ» °®´Â ÆéŸÀÌµå ¹× ÀÌÀÇ ¿ëµµ |
PCT Ãâ¿ø: OP11-1043 |
2011.09 |
Á¶¿µ¾Ö,±èÇö°æ |
¹Ì±¹ |
µî·Ï |
Æä·Ï½Ã´Ù½Å ¾ïÁ¦Á¦¸¦ À¯È¿¼ººÐÀ¸·Î Æ÷ÇÔÇÏ´Â Ç÷°ü½Å»ý¾ïÁ¦¿ë Á¶¼º¹° |
PCT Ãâ¿ø OP11-1055 |
2015.03 |
Á¶¿µ¾Ö,±èÇö°æ |
±¹³» |
µî·Ï |
³»ÇÇÀü±¸¼¼Æ÷ÀÇ Ã¼¿Ü ÁõÆø¹æ¹ý |
10-1132858 |
2012.03 |
Á¶¿µ¾Ö, ¿ÀÀºÁÖ, ¾ÈÇö¿µ, ½ÅÁ¾Ã¶ |
±¹³» |
µî·Ï |
ROCK ÀúÇØÁ¦ ½ºÅ©¸®´× ¹æ¹ý |
10-1252958 |
2013. 04 |
Á¶¿µ¾Ö, ÀÌÇö¼± |
|
|
Á¦¸ñ |
▫ The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells. Lee SW, Kim HK, Lee NH, Yi HY, Kim HS, Hong SH, Hong YK, Joe YA. Cancer Lett. 360: 195-204 (2015)
▫ Proangiogenic features of Wharton's jelly-derived mesenchymal stromal/stem cells and their ability to form functional vessels. Choi M, Lee HS, Naidansaren P, Kim HK, O E, Cha JH, Ahn HY, Yang PI, Shin JC, Joe YA. Int J Biochem Cell Biol. 45, 560-570 (2013)
▫ Efficient non-adhesive ex vivo expansion of early endothelial progenitor cells derived from CD34+ human cord blood fraction for effective therapeutic vascularization. Eunju O, Byung Hun Lee, Hyun-Young Ahn, Jong-Chul Shin, Hyun-Kyung Kim, Myungshin Kim, In-Yang Park, Yong-Gyu Park, and Young Ae Joe. FASEB Journal. 2011, 25 (1) : 159-169
▫ Antimigratory effect of TK1-2 is mediated in part by interfering with integrin a2b1. Hyun-Kyung Kim, Dae-Shik Oh, Sang-Bae Lee, Jung-Min Ha, Young Ae Joe. Molecular Cancer Therapeutics. 2008, 7 : 2133-2141
▫ Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2. Ho-Kyun Oh, Jung-Min Ha, Eunju O, Byung Hun Lee, Byoung-Shik Shim, Yong-Kil Hong, Suk Keun Lee and Young Ae Joe. Cancer Research. 2007, 67(10) : 4851-4859
|
|
|
|
|
|